
    
      This is a 53 week study consisting in a 26 week randomized, double-blind, parallel group,
      multicenter study comparing efficacy and safety of Naproxcinod, Placebo and Naproxen. The
      first 26 weeks will be followed by a naproxen-controlled treatment period up to 52 weeks and
      a 1-week post-treatment safety follow-up.
    
  